• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION AIA-900

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION AIA-900 Back to Search Results
Model Number AIA-900
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Device Issue (2379); Low Readings (2460)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 10/20/2017
Event Type  malfunction  
Manufacturer Narrative
Additional manufacturer narrative: (b)(4).Device evaluation by manufacturer: no conclusion is yet available; investigation is currently in-process.Additional information is being requested to the customer.
 
Event Description
On (b)(6) 2017 a customer reported lower than expected free thyroxine (ft4) results on patient samples with the aia-900 instrument.The customer reported that their lab normal reference range for ft4 is 0.8 - 1.8 ng/dl instead of tosoh's reference ranges of 0.75 - 1.54 ng/dl.The technical support specialist suggested running the customer's data into the ep evaluator with 20 patient results and asked for the original ft4 correlation studies.There is no indication of any patient intervention or adverse health consequences due to this event.
 
Manufacturer Narrative
Device evaluation by manufacturer: no conclusion is yet available; investigation is currently in-process.Report source: under the above section "user facility" was incorrectly selected.The only report source is "health professional".
 
Event Description
N/a.
 
Manufacturer Narrative
Device evaluation by manufacturer: multiple attempts were made to obtain additional information from the customer without any success.The free thyroxine st aia-pack ft4 assay specifications under page 8, states the following: expected values: each laboratory should determine a reference interval which corresponds to the characteristics of the population being tested.As with all diagnostic procedures, clinical results must be interpreted with regard to concomitant medications administered to the patient.Reference ranges: the interval given here was determined in serum samples from 103 apparently healthy individuals.Reference interval = 0.75 - 1.54 ng/dl (9.68 - 19.9 pmol/l).A 13-month complaint history review and service history review for similar complaints was performed for serial number (b)(4), from 20-sep-2016 through aware date 20-oct-2017.There were no other similar events identified during the searched period.The most probable cause of the reported low ft4 patient results is due to the customer using a higher reference range than the one specified by tosoh.Additional manufacturer narrative: tosoh bioscience, inc.Is submitting on behalf of the foreign manufacturer, tosoh corporation, per exemption number e2017013.Submission of this report does not constitute an admission that the importer or manufacturer's product caused or contributed to the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIA-900
Type of Device
AIA-900
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo, 105-8 623
JA  105-8623
MDR Report Key7043778
MDR Text Key93343552
Report Number8031673-2017-00113
Device Sequence Number0
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K971103
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup,Followup
Report Date 05/08/2018,05/05/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberAIA-900
Device Catalogue Number022930111
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA05/08/2018
Distributor Facility Aware Date10/20/2017
Device Age1 YR
Event Location Outpatient Diagnostic Facility
Date Report to Manufacturer05/08/2018
Initial Date Manufacturer Received 10/20/2017
Initial Date FDA Received11/17/2017
Supplement Dates Manufacturer Received10/20/2017
10/20/2017
Supplement Dates FDA Received12/30/2017
05/08/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-